How does liraglutide behave on a wide-pore C18 column compared to retatrutide?

The specifics, since they change the answer: liraglutide · a wide-pore C18 column · retatrutide.

I am trying to choose between two options that are usually discussed as though only one exists.

I am not optimising for price, but I am not indifferent to it either.

So which one, and on what grounds?

Put another way, gradient design is usually described as though it is a minor technical detail rather than the primary determinant of what the method measures.

Wider-pore phases — 300 Angstrom rather than 100 Angstrom — have faster mass transfer and narrower peaks for peptides above three kilodaltons, which is almost every peptide you will see.

Stated carefully, trifluoroacetic acid at 0.1 per cent is the standard ion-pairing agent because it suppresses tailing by neutralising the basic residues, but it also suppresses mass spectrometry signal.

Peptide impurities from solid-phase synthesis include deletion sequences, truncations from premature cleavage, racemised residues from epimerisation and oxidised variants, each of which may have different chromatographic behaviour.

The practical summary: specify the method, run the same method on every sample you compare, and use orthogonal techniques to confirm the result.

Start by understanding what the detector is measuring and what that means about how the molecule needs to be prepared and handled before injection.

Sample preparation is almost always under-appreciated — a reconstituted peptide in strong solvent will distort its own peak on the gradient.

Worth being precise here: temperature affects both the viscosity of the mobile phase and the dynamics of molecular interactions, and a method developed at 25 degrees and run at 40 degrees will not behave identically.

The selectivity of a reverse-phase separation depends on the hydrophobicity of the side-chain profile, which is why two peptides can co-elute even if they differ by a residue.

If two labs give different numbers, the method difference is the first hypothesis, not lab quality.

edited 5 Dec 2025 by Dr_Colm_Fitzhenry — fixed an arithmetic slip in the third paragraph

The underlying point is that the limit of this technique for these molecules is reaching a point where small improvements require proportionally large investments in method development.

Proline-rich sequences are particularly problematic because the isomerisation kinetics are in the same timescale as the separation, leading to split or broadened peaks at low temperature.

Reverse-phase stationary phases use C18 or C8 chains bonded to silica, and the pore size of the silica matters more for a peptide of this chain length than the ligand length does.

Inter-laboratory studies using identical methods on identical material show precision well within half a per cent when the method is locked down, pointing to method variability as the primary source of disagreement.

Ask for the chromatogram and the system suitability data, not just the number.

edited 6 Mar 2026 by deamidation_watch — reworded for clarity after a comment

In practice, system suitability is the part of a report that tells you whether the method was under control on the day you were tested, and its absence is concerning.

Acetonitrile is the organic modifier of choice because it has a good UV cutoff, a reasonable viscosity and a refractive index that minimises baseline noise.

The resolving power of a separation is quantified by the resolution parameter R, defined from the heights and widths of adjacent peaks, and pharmacopoeial methods typically demand R greater than 1.5 for a method to be considered validated.

I would caution against over-interpreting small differences between runs, because the noise floor of the method is larger than most people assume.

The practical summary: specify the method, run the same method on every sample you compare, and use orthogonal techniques to confirm the result.

Put another way, the chemistry of peptides at low pH and high organic-solvent concentration is not something most users have intuition for, which is why published methods exist.

Detector linearity is why a heavily loaded peak can give false purity by compressing the main peak height while leaving impurity shoulders unchanged.

Worth noting that the achievable resolution depends on the chemistry of the molecule — some peptide sequences separate easily while others are notoriously difficult regardless of method.

If two labs give different numbers, the method difference is the first hypothesis, not lab quality.